Peptides acting at gap junctions

Peptides

Volumn 23, Issue 9, 2002, Pages 1701-1709

  Dhein, Stefan ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Angiotensin; Antiarrhythmic peptide; Connexin; Endothelin; Extracellular loop peptide; Gap junction

Indexed keywords

ANGIOTENSIN; ANTIARRHYTHMIC PEPTIDE; ENDOTHELIN 1; GAP JUNCTION PROTEIN; MEMBRANE RECEPTOR; PEPTIDE; PROTEIN KINASE C;

AMINO ACID SEQUENCE; ANTIARRHYTHMIC ACTIVITY; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL GROWTH; CELL MEMBRANE POTENTIAL; GAP JUNCTION; HEART MUSCLE ISCHEMIA; HUMAN; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; STRUCTURE ACTIVITY RELATION;

AMINO ACID MOTIFS; ANGIOTENSINS; ANIMALS; CONNEXINS; ENDOTHELINS; GAP JUNCTIONS; HUMANS; MODELS, BIOLOGICAL; MODELS, CHEMICAL; PEPTIDES; PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 0036711308     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00113-4     Document Type: Review

References (72)

1. Aonuma S., Kohama Y., Akai K., Komiyama Y., Nakajima S., Wkabayashi M.et al. Studies on heart. XIX. Isolation of an atrial peptide that improves the rhythmicity of cultured myocardial cell clusters. Chem. Pharm. Bull. 28:1980;3332-3339.
2. Aonuma S., Kohama Y., Akai K., Iwasaki S. Studies on heart. XX. Further effects of bovine ventricle protein (BVP) and antiarrhythmic peptide (AAP) on myocardial cells in culture. Chem. Pharm. Bull. 28:1980;3340-3346.
3. Aonuma S., Kohama Y., Makino T., Fujisawa Y. Studies on heart. XXI. Amino acid sequence of antiarrhythmic peptide (AAP) isolated from atria. J. Pharm. Dyn. 5:1982;40-48.
4. Aonuma S., Kohama Y., Makino T., Hattori K. Studies on heart. XXII. Inhibitory effect of an atrial peptide on several drug induced arrhythmias in vivo. Yakugaku Zasshi. 103:1983;662-666.
5. Argentieri T., Cantor E., Wiggins J.R. Antiarrhythmic peptide has no direct cardiac actions. Experientia. 45:1989;737-738.
6. Beblo D.A., Wang H.Z., Beyer E.C., Westphale E.M., Veenstra R.D. Unique conductance, gating, and selective permeability properties of gap junction channels formed by connexin40. Circ. Res. 77:1995;813-822.
7. Bennett MVL, Zheng X, Sogin ML. The connexin family tree. In: Kanno Y, Kataoka K, Shiba Y, Shibata Y, Shimazu T, editors. Intercellular Communication Through Gap Junctions. Amsterdam: Elsevier; 1995. p. 3-8.
8. Boitano S., Evans W.H. Connexin mimetic peptides reversibly inhibit Ca(2+) signaling through gap junctions in airway cells. Am. J. Physiol. 279:2000;L619-L622.
9. Brink PR. Patch-clamp studies of gap junctions. In: Peracchia C, editor. Biophysics of Gap Junction Channels. Boca Raton, FL: CRC Press 1991. p. 29-42.
10. Brink P.R., Ramanan S.V., Christ G.J. Human connexin 43 gap junction channel gating: evidence for mode shifts and/or heterogeneity. Am. J. Physiol. 271:1996;C321-C331.
11. Brink P.R. Gap junctions in vascular smooth muscle. Acta Physiol. Scand. 164:1998;349-356.
12. Bruzzone R. Learning the language of cell-cell communication through connexin channels. Genome Biol. 2:2001;4027. [Reports].
13. Bukauskas F.F., Elfgang C., Willecke K., Weingart R. Biophysical properties of gap junction channels formed by mouse connexin40 in induced pairs of transfected human HeLa cells. Biophys. J. 68:1995;2289-2298.
14. Burt J.M., Spray D.C. Single channel events and gating behaviour of the cardiac gap junction channel. Proc. Natl. Acad. Sci. U.S.A. 85:1988;3431-3434.
15. Chaytor A.T., Evans W.H., Griffith T.M. Peptides homologous to extracellular lopp motifs of connexin43 reversibly abolish rhythmic contractile activity in rabbit arteries. J. Physiol. Lond. 503:1997;99-110.
16. Christ G.J., Brink P.R. Analysis of the presence and physiological relevance of subconducting states of connexin43-derived gap junction channels in cultured human corporal vascular smooth muscle cells. Circ. Res. 84:1999;797-803.
17. Clapham D.E., Shrier A., DeHaan R.L. Junctional resistance and action potential delay between embryonic heart cell aggregates. J. Gen. Physiol. 75:1980;633-654.
18. Dahl G., Werner R., Levine E., Rabadan-Diehl G. Mutational analysis of gap junction formation. Biophys. J. 62:1992;172-182.
19. Darrow B.J., Fast V.G., Kléber A.G., Beyer E.C., Saffitz J.E. Functional and structural assessment of intercellular communication. Increased conduction velocity and enhanced connexin expression in dibutyryl cAMP-treated cultured cardiac myocytes. Circ. Res. 79:1996;174-183.
20. Delmar M, Liu S, Morley GE, Ek JF, Pertsova RN, Aunomwo JMB, et al. Toward a molecular model for the pH regulation of intercellular communication in the heart. In: Zipes D, Jalife J, editors. Cardiac Electrophysiology. From Cell to Bedside. 2nd Ed. Philadelphia: WB Saunders, 1995. p. 135-43.
21. 2+, intercellular electrical coupling and mechanical activity in ischemic rabbit papillary muscle. Effects of preconditioning and metabolic blockade. Circ. Res. 79:1996;237-246.
22. De Mello W.C. Effects of intracellular injection of calcium and strontium on cell communication in heart. J. Physiol. 250:1975;231-245.
23. De Mello W.C., Altieri P. The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II. J. Cardiovasc. Pharmacol. 20:1992;643-651.
24. De Mello W.C. Is an intracellular renin-angiotensin system involved in control of cell communication in heart? J. Cardiovasc. Pharmacol. 23:1994;640-646.
25. De Mello W.C. Renin-angiotensin system and cell communication in the failing heart. Hypertension. 27:1996;1267-1272.
26. Dhein S., Manicone N., Müller A., Gerwin R., Ziskoven U., Irankahi A.et al. A new synthetic antiarrhythmic peptide reduces dispersion of epicardial activation recovery interval and diminishes alterations of epicardial activation patterns induced by regional ischemia. Naunyn Schmiedeberg's Arch. Pharmacol. 350:1994;174-184.
27. Dhein S., Tudyka T. Therapeutic potential of antiarrhythmic peptides. Cellular coupling as a new antiarrhythmic target. Drugs. 49:1995;851-855.
28. Dhein S, Cardiac Gap Junctions. Physiology, Regulation, Pathophysiology and Pharmacology. Basel: Karger Verlag, 1998. p. 2-120.
29. Dhein S. Gap junction channels in the cardiovascular system: pharmacological and physiological modulation. Trends Pharmacol. Sci. 19:1998;229-241.
30. Dhein S, Weng S, Grover R, Tudyka T, Gottwald M, Schaefer T, et al. Protein kinase Cα mediates the effect of antiarrhythmic peptide on gap junction conductance. Cell Adhesion Commun., 2002;8 (in press).
31. Dhein S., Weng S., Schaefer T., Grover R., Polontchouk L. Role of protein kinase C in the action of antiarrhythmic peptides. FASEB J. 15(Suppl.):2001;465.1.
32. Dhein S., Weng S., Polontchouk L., Grover R., Schaefer T. Pharmacological modification of gap junctional coupling by antiarrhythmic peptides. Role of PKC. Naunyn Schmiedeberg's Arch. Pharmacol. 363(Suppl.):2001;R99.
33. Doble B.W., Ping P., Kardami E. The ε subtype of protein kinase C is required for cardiomyocyte connexin-43 phosphorylation. Circ. Res. 86:2000;293-301.
34. Dodge S.M., Beardslee M.A., Darrow B.J., Green K.G., Beyer E.C., Saffitz J.E. Effects of angiotensin II on expression of the gap junction channel protein connexin43 in neonatal rat ventricular myocytes. Am. J. Coll. Cardiol. 32:1998;800-807.
35. Fallon R.F., Goodenough D.A. Five hour half-life of mouse liver gap junction protein. J. Cell. Biol. 127:1981;343-355.
36. Goshima K. Arrhythmic movements of myocardial cells in culture and their improvement with antiarrhythmic drugs. J. Mol. Cell. Cardiol. 8:1976;217-238.
37. Grover R., Dhein S. Spatial structure determination of antiarrhythmic peptide using nuclear magnetic resonance spectroscopy. Peptides. 19:1998;1725-1729.
38. Grover R., Dhein S. Structure-activity relationships of novel peptides related to the antiarrhythmic peptide AAP10 which reduce the dispersion of epicardial action potential duration. Peptides. 22:2001;1011-1021.
39. Janse M.J., Wit A.L. Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol. Rev. 69:1989;1049-1169.
40. 90 dispersion and prevents ventricular fibrillation in isolated perfused rabbit hearts. FASEB J. 14(4):2000;A698. [abstract].
41. Kléber A.G., Riegger C.B., Janse M.J. Electrical uncoupling and increase of extracellular resistance after induction of ischemia in isolated, arterially perfused rabbit papillary muscle. Circ. Res. 61:1987;271-279.
42. Kohama Y., Kawahara Y., Okabe M., Aonuma S. Determination of immunoreactive antiarrhythmic peptide (AAP) in rats. J. Pharmacobiol. Dyn. 8:1985;1024-1031.
43. Kohama Y., Iwabuchi K., Shibahara T., Okabe M., Mimura T. Response of immunoreactive antiarrhythmic peptide (IR-AAP) level associated with experimental arrhythmia in rats. J. Pharmacobio. Dyn. 9:1986;806-810.
44. Kohama Y., Okimoto N., Mimura T., Fukaya C., Watanabe M., Yokoyama K. A new antiarrhythmic peptide, N-3-(4-hydroxyphenyl)propionyl-Pro-Hyp-Gly-Ala-Gly. Chem. Pharm. Bull. 35:1987;3928-3930.
45. Kohama Y., Kuwahara S., Yamamoto K., Aonuma S. Effect of N-3-(4-hydroxyphenyl)propionyl-Pro-Pro-Gly-Ala-Gly on calcium-induced arrhythmias. Chem. Pharm. Bull. 36:1988;4597-4599.
46. Kwak B.R., Hermanns M.M.P., De Jonge H.R., Lohmann S.M., Jongsma H.J., Chanson M. Differential regulation of distinct types of gap junction channels by similar phosphorylating conditions. Mol. Biol. Cell. 6:1995;1707-1719.
47. Kwak B.R., Van Veen T.A.B., Analbers L.J.S., Jongsma H.J. TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels. Exp. Cell Res. 220:1995;456-463.
48. Kwak B.R., Jongsma H.J. Selective inhibition of gap junction channel activity by synthetic peptides. J. Physiol. Lond. 516:1999;679-685.
49. Kundu B. Synthesis and CD characteristics of position 3 analogues of antiarrhythmic peptide. Collect. Czech. Chem. Commun. 54:1989;1422-1430.
50. Kundu B., Rizvi S.Y., Mathur K.B.et al. Antiarrhythmic activity of a novel analogue of AAP. Collect. Czech. Chem. Commun. 55:1990;575-580.
51. Kuo C.S., Munakata K., Reddy C.P., Surawicz B. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations. Circulation. 67:1983;1356-1367.
52. Laird D.W. The life cycle of a connexin: gap junction formation removal and degradation. J. Bioenerg. Biomembr. 28:1996;311-317.
53. Lau A.F., Kurata W.E., Kanemitsu M.Y., Loo L.M.W., Warn-Cramer B.J., Eckhart W.et al. Regulation of connexin 43 function by activated tyrosine protein kinases. J. Bioenerg. Biomembr. 28:1996;359-368.
54. Lesh M.D., Pring M., Spear J.F. Cellular uncoupling can unmask dispersion of action potential duration in ventricular myocardium. Circ. Res. 65:1989;1426-1440.
55. i on nexal membrane resistance. Pflüger's Arch. 409:1987;394-402.
56. Meyer R.A., Laird D., Revel J.P., Johnson R.G. Inhibition of gap junction and adherens junction assembly by connexin and A-CAM antibodies. J. Cell Biol. 119:1992;179-189.
57. Müller A., Gottwald M., Tudyka T., Linke W., Klaus W., Dhein S. Increase in gap junction conductance by an antiarrhythmic peptide. Eur. J. Pharmacol. 327:1997;65-72.
58. Müller A., Schaefer T., Linke W., Tudyka T., Gottwald M., Klaus W.et al. Actions of the antiarrhythmic peptide AAP10 on cellular coupling. Naunyn Schmiedeberg's Arch. Pharmacol. 356:1997;76-82.
59. Musil L.S., Goodenough D.A. Multisubunit assembly of an integral plasma membrane channel protein gap junction connexin43, occurs after exit from the ER. Cell. 74:1993;1065-1077.
60. Noma A., Tsuboi N. Dependence of junctional conductance on proton, calcium and magnesium ions in cardiac paired cells of guinea pig. J. Physiol. Lond. 382:1987;193-211.
61. Polontchouk L, Ebelt B, Jackels M, Dhein S. Chronic effects of endothelin-1 and angiotensin II on gap junctions and intercellular communication in cardiac cells. FASEB J 2001;Nov 14:PMID 11709493.
62. Spach M.S., Dolber P.C. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ. Res. 58:1986;356-371.
63. Spach M.S., Josephson M.E. Initiating reentry: the role of non-uniform anisotropy in small circuits. J. Cardiovasc. Electrophysiol. 5:1994;182-209.
64. Spray D.C., White R.L., Mazet F., Bennett M.V.L. Regulation of gap junction conductance. Am. J. Physiol. 248:1985;H753-H764.
65. Spray DC, Bennett MVL, Campos de Carvalho AC, Eghbali B, Moreno AP, Verselis V. Transjunctional voltage dependence of gap junction channels. In: Peracchia C, editor. Biophysics of Gap Junction Channels. Boca Raton, FL: CRC Press 1991. p. 97-116.
66. Sugiura H., Toyama J., Tsuboi N., Kamiya K., Kodama I. ATP directly affects junctional conductance between paired ventricular myocytes isolated from guinea pig heart. Circ. Res. 66:1990;1095-1102.
67. Valiunas V., Bukauskas F.F., Weingart R. Conductances and selective permeability of connexin43 gap junction channels examined in neonatal rat heart cells. Circ. Res. 80:1997;708-719.
68. Valiunas V., Weingart R., Brink P.R. Formation of heterotypic gap junction channels by connexins 40 and 43. Circ. Res. 86:2000;E42-E49.
69. Valiunas V., Vogel R., Weingart R. The kinetics of gap junction currents are sensitive to the ionic composition of the pipette solution. Pflügers Arch. 440:2000;835-842.
70. Valiunas V., Gemel J., Brink P.R., Beyer E.C. Gap junction channels formed by coexpressed connexin40 and connexin43. Am. J. Physiol. 281:2001;H1675-H1689.
71. Warner A., Clements D.K., Parikh S., Evans W.H., DeHaan R.L. Specific motifs in the external loops of connexin proteins can determine gap junction formation between chick heart myocytes. J. Physiol. Lond. 488:1995;721-728.
72. Weng S, Lauven M, Schaefer T, Polontchouk L, Dhein S. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation. FASEB J 2002 (in press).